109 related articles for article (PubMed ID: 26772316)
1. Sweet beginning for cancer stem cells.
Baum LG
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):815-6. PubMed ID: 26772316
[No Abstract] [Full Text] [Related]
2. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.
Cheung SK; Chuang PK; Huang HW; Hwang-Verslues WW; Cho CH; Yang WB; Shen CN; Hsiao M; Hsu TL; Chang CF; Wong CH
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):960-5. PubMed ID: 26677875
[TBL] [Abstract][Full Text] [Related]
3. Nonlinearity of measurements of a tumor marker for breast cancer.
Cooper EH; Forbes MA; Laurence V; Beya MF; de Chastonay J
Clin Chem; 1990 Feb; 36(2):408-9. PubMed ID: 2406045
[No Abstract] [Full Text] [Related]
4. Breast cancer stem cell markers - the rocky road to clinical applications.
Dontu G
Breast Cancer Res; 2008; 10(5):110. PubMed ID: 18828879
[TBL] [Abstract][Full Text] [Related]
5. [Cell surface carbohydrate and cancer stem cells].
Lin WM; Cao Y
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):641-3. PubMed ID: 24314258
[No Abstract] [Full Text] [Related]
6. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
7. The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.
Cabuk D; Yetimoglu E; Simsek T; Gacar G; Subasi C; Canturk Z; Ercin C; Karaoz E; Uygun K
J BUON; 2016; 21(5):1121-1128. PubMed ID: 27837613
[TBL] [Abstract][Full Text] [Related]
8. [Basic study of CA549, a new tumor marker for breast cancer, and evaluation of its clinical usefulness].
Yamaguchi A; Ushigome M; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Mar; 30(3):317-22. PubMed ID: 8479100
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of CD44(+)ESA(+)CD24(-/low), stem cell markers for breast cancer, in non-small-cell lung carcinoma].
Lu ZQ; Li HG; Zhang HZ; Fan MJ; Shen XM; He XX
Ai Zheng; 2008 Jun; 27(6):575-9. PubMed ID: 18570728
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate tumor marker: basis for a simple test for colorectal cancer.
Shamsuddin AM; Sakamoto K
Adv Exp Med Biol; 1994; 354():85-99. PubMed ID: 8067291
[No Abstract] [Full Text] [Related]
12. STn and prognosis in breast cancer.
Leivonen M; Nordling S; Lundin J; von Boguslawski K; Haglund C
Oncology; 2001; 61(4):299-305. PubMed ID: 11721177
[TBL] [Abstract][Full Text] [Related]
13. Women at risk for ovarian cancer.
Taher MA
J Ultrasound Med; 1988 Dec; 7(12):696-7. PubMed ID: 3236393
[No Abstract] [Full Text] [Related]
14. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
15. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
Kausitz J
Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
[No Abstract] [Full Text] [Related]
16. [Ca 125 in epithelial ovarian cancers of FIGO stage I].
Nagele F; Kurz C; Vavra N; Sevelda P
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():291-2. PubMed ID: 8118320
[No Abstract] [Full Text] [Related]
17. [Cancer stem cells in colon cancer].
Pannequin J
Bull Cancer; 2017 Dec; 104(12):1072-1074. PubMed ID: 29153380
[No Abstract] [Full Text] [Related]
18. Tumor markers for early diagnosis of cholangiocarcinoma.
Sirisinha S
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):1-3. PubMed ID: 2546569
[No Abstract] [Full Text] [Related]
19. Sialyl-Tn expression in gastric carcinoma.
Carneiro F; David L; Sobrinho-Simões M
Eur J Cancer; 1994; 30A(9):1398-9. PubMed ID: 7999432
[No Abstract] [Full Text] [Related]
20. Immunodiagnosis of ovarian tumors.
Jacobs I; Bast RC
Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
